Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose oral minoxidil is safe for treating children's hair disorders.

Extracellular vesicles show promise as treatments but need more research for safety and effectiveness.

Teledermatology became a valuable and convenient tool for skin care during the COVID-19 pandemic.

Low testosterone and SHBG levels are linked to higher COVID-19 death rates.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

People with autism are more likely to develop alopecia areata than those without autism.

Hispanic/Latinx patients with alopecia areata often have it before age 40, with females and certain health conditions like rheumatoid arthritis more commonly affected.

Teledermatology is highly effective for diagnosing and managing hair loss.

The Fibonacci 'snail' flap heals faster and looks better than skin grafts for scalp reconstruction.

Regenerative treatments improve hair growth in androgenetic alopecia with mild side effects.

Alopecia areata greatly affects people's life quality, mental health, and work life.

Women with PCOS have higher levels of thyroid autoantibodies.

Finasteride and dutasteride can improve hair loss in women, but more research is needed.

Oral testosterone therapy raises heart risk more than other methods.

Certain nail conditions can suggest thyroid problems, with different symptoms for underactive (slow, thin nails) and overactive (spoon-shaped, brittle nails) thyroid.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Subclinical hypothyroidism in women with PCOS affects thyroid and hormone interactions but not ovary structure.

Androgenetic alopecia is linked to factors like age, family hair loss history, diet, and health conditions.

GLP-1 receptor agonists may help or harm hair health, needing more research.

Exosome-based therapies show promise for treating alopecia areata but need more research.

Intralesional dutasteride improves hair growth in androgenic alopecia with minimal side effects.

Young transgender, gender diverse, and nonbinary people on spironolactone have a low risk of high potassium, so frequent monitoring may not be needed.

Erosive lichen sclerosus is a distinct subtype with specific skin features, and treatment led to complete resolution in half of the cases.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

Middle-aged patients, those in the Northeast, with comprehensive insurance, extensive hair loss, or additional health issues, and young or older females face higher alopecia areata medical costs.

Transgender women have similar fitness to cisgender women, while transgender men have higher fat and lower strength than cisgender men; hormone therapy affects body composition and strength.

Baricitinib effectively promotes hair regrowth in both scalp and nonscalp areas for alopecia areata universalis patients.

Keloids on the penis are rare, often triggered by circumcision, and rarely recur after surgery.

Early biopsy and targeting inflammation can improve treatment for hair loss in androgenetic alopecia.